![Professor Simon Cool](/sites/default/files/profiles/34187.jpeg)
Overview
Background
Professor Simon Cool is Professor of Bioengineering and Director of the UQ Advanced Cell Therapy Manufacturing Initiative in the School of Chemical Engineering at the University of Queensland.
Professor Cool began his scientific career at the University of Queensland more than 20 years ago. He received his BSc (hons) and PhD degrees from the University of Queensland, where he subsequently held a faculty position in the School of Biomedical Sciences. His areas of studies have included age-related changes in the structure of bone and teeth and the extracellular matrix compartment of skeletal tissue that guide stem cell behaviour and wound repair. Professor Cool was invited to join the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in 2003 as a Principal Investigator. He then joined A*STAR’s Institute of Medical Biology (IMB) in 2008, shortly after its inception, to further his research in regenerative medicine, serving as Senior Principal Investigator of the Glycotherapeutics Group. In October 2020, Professor Cool re-joined the Institute of Molecular and Cell Biology (IMCB) as a Research Director, Glycotherapeutics, where he focused on developing novel glycosaminoglycan biomolecules that enhance wound repair and control adult human mesenchymal stem cell activity.
Professor Cool has 117 patent applications across 26 families with 51 granted in the fields of glycosaminoglycan biochemistry, regenerative medicine and stem cell science. He has more than 150 publications and continues to foster strong strategic collaborations both nationally and internationally with academic and industry groups. He has a strong biomanufacturing and translational focus with experience in taking glycosaminoglycan-based devices through discovery RnD on to pre-clinical and clinical testing. Professor Cool also has an entrepreneurial and licensing background having successfully spun-off some of his technology to a US-based regenerative medicine start-up company, SMC Biotechnology Ltd. Professor Cool holds a Visiting Professor appointment at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore and an Adjunct Professor (Research) appointment in the Orthopaedic Department at the National University of Singapore (NUS). Prior to his move back to UQ, he previously held the position of Treasurer, Tissue Engineering and Regenerative Medicine International Society, Asia Pacific Chapter (TERMIS-AP) and Treasurer, Stem Cell Society Singapore (SCSS). He also held senior leadership positions in several Singapore-based R&D programmes, notably as Director, Allogeneic Stem Cell Manufacturing (ASTEM) and Theme Leader in Advanced Manufacturing for Biological Materials (AMBM). Prof Cool currently serves on the Editorial Board of the journals Biomaterials, Tissue Engineering and Regenerative Medicine, and is Asia-Pacific Regional Editor for Stem Cells and Development.
Availability
- Professor Simon Cool is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science (Honours), unknown
- PhD, unknown
Research interests
-
Manufacturing highly-potent stem cells
Developing novel media, assays, and processes to enable the scale-up manufacturing of cell therapy products.
-
Rejuvenation of ageing stem cells
Developing innovative methods to rejuvenate ageing stem cells to generate best-in-class cell banks for therapeutic use.
-
Synthesis of glycosaminoglycans as medical devices
Developing scalable methods to manufacture fully synthetic glycosaminoglycans for use as media additives, biocoatings and medical devices for treating disease, injury or trauma.
-
Modification of stem cells to improve their therapeutic utility
Altering stem cell surfaces to encourage protein binding and drive stem cell fate decisions for improved therapeutic efficacy.
-
Enhanced angiogenesis through glycosaminoglycan administration and medical device formulation
Developing pro-angiogenic microenvironments using novel glycosaminoglycan formulations.
Research impacts
I have over 25 years of leadership in identifying novel heparan sulphate (HS) glycosaminoglycan (GAG) sugars within stem cell niches and repairing tissues. These sugars sequester, protect, hold, and present key growth factors to stem cells. I have successfully used this complexation paradigm to unlock pathways critical to stem cell biology, mainly signalling cascades essential for maintaining naïve phenotypes. I have also shown that this strategy effectively develops bioadditives for manufacturing cell therapy devices for treating vascular ischemia/stroke, cartilage regeneration, and bone repair. A significant part of this pioneering effort has been manufacturing HS variants that mimic sugars in native tissues. Anchoring this strategy is my novel discovery platform that identifies specific domains in HS chains that form complexes with growth factors and growth factor receptors to generate powerful signalling complexes that mediate cell-fate decisions and potentiate tissue regeneration. Using this blueprint, I have developed a library of bio-inspired HS variants and subjected them to structure/function analyses. I strongly advocate for the safety/tolerability testing of HS materials and continue to lead industry-based projects in this area. I have considerable experience leading outcome-focused multidisciplinary research teams across all scientific discovery and translation aspects, with a proven track record in developing transformative technology and biotechnology entrepreneurship. I lead a long-standing effort to bank mesenchymal stem cells cultured in HS-supplemented media to treat age-related diseases (pre-clinical stage only) and have been working to transition this project to a commercial facility to develop suitable manufacturing and banking protocols for future clinical testing. Through these various opportunities, I have mentored numerous PhD students in Australia, Singapore, and the UK, which has helped accelerate research opportunities and led to significant gains in generating novel findings.
Works
Search Professor Simon Cool’s works on UQ eSpace
2015
Conference Publication
High-throughput microfluidic screening of human mesenchymal Stem Cell proliferative responses to FGF-2 and heparan sulfates
Titmarsh, D., Glass, N., Nurcombe, V., Cooper-White, J. and Cool, S. (2015). High-throughput microfluidic screening of human mesenchymal Stem Cell proliferative responses to FGF-2 and heparan sulfates. 4th TERMIS World Congress, Boston, MA USA, 8-11 September 2015. New Rochelle, NY USA: Mary Ann Liebert.
2015
Journal Article
Establishing criteria for human mesenchymal stem cell potency
Samsonraj, Rebekah M., Rai, Bina, Sathiyanathan, Padmapriya, Puan, Kia Joo, Rötzschke, Olaf, Hui, James H., Raghunath, Michael, Stanton, Lawrence W., Nurcombe, Victor and Cool, Simon M. (2015). Establishing criteria for human mesenchymal stem cell potency. Stem Cells, 33 (6), 1878-1891. doi: 10.1002/stem.1982
2014
Journal Article
Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity
Okolicsanyi, Rachel K., Van Wijnen, Andre J., Cool, Simon M., Stein, Gary S., Griffiths, Lyn R. and Haupt, Larisa M. (2014). Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity. Journal of Cellular Biochemistry, 115 (5), 967-976. doi: 10.1002/jcb.24746
2014
Journal Article
Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy
Wang, Chunming, Poon, Selina, Murali, Sadasivam, Koo, Chuay-Yeng, Bell, Tracey J., Hinkley, Simon F., Yeong, Huiqing, Bhakoo, Kishore, Nurcombe, Victor and Cool, Simon M. (2014). Engineering a vascular endothelial growth factor 165-binding heparan sulfate for vascular therapy. Biomaterials, 35 (25), 6776-6786. doi: 10.1016/j.biomaterials.2014.04.084
2014
Journal Article
New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination
Ayerst, Bethanie I., Day, Anthony J., Nurcombe, Victor, Cool, Simon M. and Merry, Catherine L.R. (2014). New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination. Biochemical Society Transactions, 42 (3), 703-709. doi: 10.1042/BST20140031
2013
Journal Article
FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1
Dombrowski, Christian, Helledie, Torben, Ling, Ling, Grünert, Martin, Canning, Claire A., Jones, C. Michael, Hui, James H., Nurcombe, Victor, Van Wijnen, Andre J. and Cool, Simon M. (2013). FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1. Stem Cells, 31 (12), 2724-2736. doi: 10.1002/stem.1514
2013
Journal Article
MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma
Van Der Deen, Margaretha, Taipaleenmäki, Hanna, Zhang, Ying, Teplyuk, Nadiya M., Gupta, Anurag, Cinghu, Senthilkumar, Shogren, Kristen, Maran, Avudaiappan, Yaszemski, Michael J., Ling, Ling, Cool, Simon M., Leong, David T., Dierkes, Christian, Zustin, Jozef, Salto-Tellez, Manuel, Ito, Yoshiaki, Bae, Suk-Chul, Zielenska, Maria, Squire, Jeremy A., Lian, Jane B., Stein, Janet L., Zambetti, Gerard P., Jones, Stephen N., Galindo, Mario, Hesse, Eric, Stein, Gary S. and Van Wijnen, Andre J. (2013). MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. Journal of Biological Chemistry, 288 (29), 21307-21319. doi: 10.1074/jbc.M112.445890
2013
Journal Article
Affinity-selected heparan sulfate for bone repair
Murali, S., Rai, B., Dombrowski, C., Lee, J. L.J., Lim, Z. X.H., Bramono, D. S., Ling, L., Bell, T., Hinkley, S., Nathan, S. S., Hui, J. H., Wong, H. K., Nurcombe, V. and Cool, S. M. (2013). Affinity-selected heparan sulfate for bone repair. Biomaterials, 34 (22), 5594-5605. doi: 10.1016/j.biomaterials.2013.04.017
2013
Journal Article
Telomere length analysis of human mesenchymal stem cells by quantitative PCR
Samsonraj, Rebekah M., Raghunath, Michael, Hui, James H., Ling, Ling, Nurcombe, Victor and Cool, Simon M. (2013). Telomere length analysis of human mesenchymal stem cells by quantitative PCR. Gene, 519 (2), 348-355. doi: 10.1016/j.gene.2013.01.039
2013
Book Chapter
Heparanated surfaces
Nurcombe, Victor, Birch, William R. and Cool, Simon M. (2013). Heparanated surfaces. Handbook of Biofunctional Surfaces. (pp. 617-638) Boca Raton, FL United States: Pan Stanford Publishing.
2013
Journal Article
The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation
Bhakta, Gajadhar, Lim, Zophia X.H., Rai, Bina, Lin, Tingxuan, Hui, James H., Prestwich, Glenn D., Van Wijnen, Andre J., Nurcombe, Victor and Cool, Simon M. (2013). The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. Acta Biomaterialia, 9 (11), 9098-9106. doi: 10.1016/j.actbio.2013.07.008
2012
Journal Article
Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2
Bhakta, Gajadhar, Rai, Bina, Lim, Zophia X.H., Hui, James H., Stein, Gary S., van Wijnen, Andre J., Nurcombe, Victor, Prestwich, Glenn D. and Cool, Simon M. (2012). Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials, 33 (26), 6113-6122. doi: 10.1016/j.biomaterials.2012.05.030
2012
Journal Article
Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow
Helledie, Torben, Dombrowski, Christian, Rai, Bina, Lim, Zophia X.H., Hin, Ian Lee Hock, Rider, David A., Stein, Gary S., Hong, Wanjin, Van Wijnen, Andre J., Hui, James H., Nurcombe, Victor and Cool, Simon M. (2012). Heparan sulfate enhances the self-renewal and therapeutic potential of mesenchymal stem cells from human adult bone marrow. Stem Cells and Development, 21 (11), 1897-1910. doi: 10.1089/scd.2011.0367
2012
Journal Article
Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces
Heng, Boon Chin, Li, Jian, Chen, Allen Kuan-Liang, Reuveny, Shaul, Cool, Simon M., Birch, William R. and Oh, Steve Kah-Weng (2012). Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells and Development, 21 (10), 1701-1715. doi: 10.1089/scd.2011.0509
2012
Journal Article
Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2)
Bramono, Diah S., Murali, Sadasivam, Rai, Bina, Ling, Ling, Poh, Wei Theng, Lim, Zophia Xuehui, Stein, Gary S., Nurcombe, Victor, van Wijnen, Andre J. and Cool, Simon M. (2012). Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone, 50 (4), 954-964. doi: 10.1016/j.bone.2011.12.013
2011
Journal Article
The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen fibers and hyaluronic acid hydrogel
Ekaputra, Andrew K., Prestwich, Glenn D., Cool, Simon M. and Hutmacher, Dietmar W. (2011). The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (ɛ-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials, 32 (32), 8108-8117. doi: 10.1016/j.biomaterials.2011.07.022
2011
Journal Article
Multifunctional silica nanoparticles with potentials of imaging and gene delivery
Bhakta, Gajadhar, Sharma, Rakesh Kumar, Gupta, Nikesh, Cool, Simon, Nurcombe, Victor and Maitra, Amarnath (2011). Multifunctional silica nanoparticles with potentials of imaging and gene delivery. Nanomedicine: Nanotechnology, Biology, and Medicine, 7 (4), 472-479. doi: 10.1016/j.nano.2010.12.008
2011
Journal Article
The effect of human bone marrow stroma-derived heparan sulfate on the Ex vivo expansion of human cord blood hematopoietic stem cells
Bramono, Diah S., Rider, David A., Murali, Sadasivam, Nurcombe, Victor and Cool, Simon M. (2011). The effect of human bone marrow stroma-derived heparan sulfate on the Ex vivo expansion of human cord blood hematopoietic stem cells. Pharmaceutical Research, 28 (6), 1385-1394. doi: 10.1007/s11095-010-0352-y
2011
Journal Article
Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells
Murali, Sadasivam, Leong, Denise F. M., Lee, Jaslyn J. L., Cool, Simon M. and Nurcombe, Victor (2011). Comparative assessment of the effects of gender-specific heparan sulfates on mesenchymal stem cells. Journal of Biological Chemistry, 286 (20), 17755-17765. doi: 10.1074/jbc.M110.148874
2011
Journal Article
Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells
Yap, Lynn Y.W., Li, Jian, Phang, In Yee, Ong, Lay Ting, Ow, Jo'An Zhu-En, Goh, James C.H., Nurcombe, Victor, Hobley, Jonathan, Choo, Andre B.H., Oh, Steve K.W., Cool, Simon M. and Birch, William R. (2011). Defining a threshold surface density of vitronectin for the stable expansion of human embryonic stem cells. Tissue Engineering - Part C: Methods, 17 (2), 193-207. doi: 10.1089/ten.tec.2010.0328
Funding
Past funding
Supervision
Availability
- Professor Simon Cool is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Orthopaedic application of glycotherapeutics linked to implantable scaffolds
We have developed a range of glycosaminoglycan compounds that drive cell fate decisions through complexation with protein/protein receptors that are important for bone formation. Here we seek to coat implantable scaffolds (doi: 10.1116/1.4933109) with these materials and to progress these implantable orthopaedic devices through a range of preclinical models in an effort to define their future clinical utility.
-
Age-related changes in stem cell glycosaminoglycans
We have identified a range of glycosaminoglycan-altering enzymes that can potentially drive senescent phenotypes linked to stem cell ageing during scale-up manufacturing. Here we seek to develop glycosaminoglycan variants capable of replenishing these lost glycosaminoglycan structures that can restore growth and potency.
Supervision history
Current supervision
-
Doctor Philosophy
Elucidating the effects of potency biomarkers on cellular reprogramming and differentiation in adult stem cells
Principal Advisor
Other advisors: Professor Nathan Palpant, Dr Alex Smith
-
Doctor Philosophy
Understanding the role of electrical fields on cell fates
Associate Advisor
Other advisors: Professor Justin Cooper-White
-
Doctor Philosophy
Regenerative engineering solutions for rotator cuff repair using stem cells and bioactives
Associate Advisor
Other advisors: Professor Lisbeth Grondahl, Professor Justin Cooper-White
-
Doctor Philosophy
Fabrication of sulfated alginate nano-particles for protein delivery
Associate Advisor
Other advisors: Professor Lisbeth Grondahl, Dr Ali Shokoohmand
Completed supervision
-
-
2009
Doctor Philosophy
Heparan sulphate releasing biomaterials for tissue engineering
Principal Advisor
Other advisors: Professor Lisbeth Grondahl
-
2005
Doctor Philosophy
AUGMENTING OSTEOGENESIS THROUGH CHEMICAL AND MECHANICAL STIMULATION: THE USE OF LOADING AND HEPARAN SULFATE TO ENHANCE IN VITRO AND IN VIVO BONE FORMATION
Principal Advisor
-
2008
Doctor Philosophy
THE NOVEL ISOLATION OF HEPARAN SULFATE WITH A SPECIFIC AFFINITY FOR BONE MORPHOGENTIC PROTEIN 2
Associate Advisor
Other advisors: Associate Professor Peter Noakes
Media
Enquiries
For media enquiries about Professor Simon Cool's areas of expertise, story ideas and help finding experts, contact our Media team: